NCT07760623

Brief Summary

To evaluate both sides of the common carotid artery, renal artery, and femoral artery in Hypertension patient that cause of systemic arterial hypertension and/or the effects of target organ damage, both structural and functional markers.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
10mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Aug 2026May 2027

First Submitted

Initial submission to the registry

July 30, 2026

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 12, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2027

Last Updated

August 12, 2026

Status Verified

August 1, 2026

Enrollment Period

5 months

First QC Date

July 30, 2026

Last Update Submit

August 5, 2026

Conditions

HypertensionHypertension (HTN)Artery DiseaseTarget Organ Damage

Keywords

hypertensioncommon carotid arteryrenal arteryfemmoral arteryvascular resistant

Outcome Measures

Primary Outcomes (1)

  • Median of diameter of common carotid artery, renal artery and femoral artery in hypertension patients.

    Radiographic measurement includes ultrasonography, CT/MR imaging, and intravascular contrast media imaging that measure the diameter in cm. unit of any side of common carotid artery and/or renal artery and/or femoral artery in hypertension patients.

    1 years

Secondary Outcomes (3)

  • Common Carotid Artery Function

    1 year

  • Renal Artery Function

    1 year

  • Femoral Artery Function

    1 year

Other Outcomes (1)

  • All-cause mortality outcomes

    1 year

Study Arms (3)

Common Carotid Artery

The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Common Carotid Artery.

Other: Diameter measurementOther: Velocity

Renal Artery

The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Renal Artery.

Other: Diameter measurementOther: Velocity

Femoral Artery

The group of hypertensive patients were underwent in angiographic imaging such as ultrasonography, CR/MR, real-time intravascular contrast media angiography of any side of Femoral Artery.

Other: Diameter measurementOther: Velocity

Interventions

Diameter measurementOTHER

Radiographic diameter in cm. of each side of one of Common Carotid Artery, Renal Artery and Femoral Artery

Common Carotid ArteryFemoral ArteryRenal Artery
VelocityOTHER

Any kind of radiographic measurement of Peak Systolic Velocity and/or End Diastolic Velocity (cm/s)

Common Carotid ArteryFemoral ArteryRenal Artery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hypertensive patient who underwent the radiographic measurement of structure and function of carotid artery, renal artery or femoral artery

You may qualify if:

  • Adults ≥18 years with diagnosed hypertension by a clinician, both untreated and treated, including successfully treated participants.
  • Imaging evidence of at least 1 list of
  • Common carotid artery
  • Renal artery
  • Femoral artery

You may not qualify if:

  • Fatal pathology and imaging
  • Pediatric or pregnant participants
  • Small vessel angiogram
  • Intravascular endoscopy
  • Intra-operative estimation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Invstigation center

Vadhana, Bangkok, 10110, Thailand

Location

Related Links

MeSH Terms

Conditions

Hypertension

Interventions

Blood Flow Velocity

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisHemorheologyHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Central Study Contacts

Nathaphong Dejthida, Medical Degree

CONTACT

+66819220662bnnatto@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

July 30, 2026

First Posted

August 12, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

May 18, 2027

Last Updated

August 12, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations

TH(1)